Belinda M. Kumpel - Concepedia

Author

Belinda M. Kumpel

Also Known As

Axel 26 Greiner, B KUMPEL, B Kumpel, B M KUMPEL, B M Kumpel, B. Kumpel, B. M. Kumpel, B.-M. Kumpel, B.M Kumpel, B.M. KUMPEL

105

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

NHS Blood and Transplant Bristol Institute for Transfusion Sciences Southmead Hospital University of Bristol Shanghai Blood Center

About

Belinda M. Kumpel is an author at NHS Blood and Transplant specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	32	1.3K
2	Allergy	17	18	701
3	Health Sciences	10	10	371
4	Natural Sciences	3	3	261
5	Biochemistry	2	2	193

Belinda M. Kumpel

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy Rick Kapur, Iwan Kustiawan, Anne Vestrheim, Blood	2013	217
Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. Belinda M. Kumpel, T. W. Rademacher, G.A.W. Rook, PubMed GlycobiologyImmune RegulationImmunologyGlycosylation AnalysisImmunologic Mechanism	1994	107
Human monoclonal anti‐D antibodies. I. THEIR PRODUCTION, SEROLOGY, QUANTITATION AND POTENTIAL USE AS BLOOD GROUPING REAGENTS Belinda M. Kumpel, G. D. Poole, B. A. Bradley British Journal of Haematology	1989	93
Protein-sequence studies on Rh-related polypeptides suggest the presence of at least two groups of proteins which associate in the human red-cell membrane Neil D. Avent, K. Ridgwell, William J. Mawby, Biochemical Journal Proteinlipid InteractionProtein SecretionRed CellsImmunologyMolecular Biology	1988	86
Ultrastructural localization of glycoprotein IIIa (GPIIIa, β3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy Belinda M. Kumpel, Karin Sibley, David J. Jackson, Transfusion	2008	73
The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment. Belinda M. Kumpel, Yan Wang, Helen Griffiths, PubMed Immunocytochemical TechniqueImmunotoxicologyGlycobiologyImmunologyIgg Effector Function	1995	71
Clearance of Rh D-positive red cells with monoclonal anti-D Amanda Thomson, M. Contreras, P. Teesdale, The Lancet Monoclonal Anti-dImmunologyHematologyBlood CellCell Proliferation	1990	68
The biological activity of human monoclonal IgG anti-D is reduced by β-galactosidase treatment Belinda M. Kumpel, Yan Wang, Helen L. Griffiths, Human Antibodies ImmunohematologyImmunodeficienciesGlycobiologyImmune RegulationImmunology	1995	68
Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes. Edith Wiener, V. M. Jolliffe, H. C. F. Scott, PubMed Clinical ImmunologyRed CellsImmunologyImmunologic MechanismImmune System	1988	63
Section 1B: Rh flow cytometryCoordinatorˈs report.Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination Willy A. Flegel, Vladka Čurin Šerbec, M. Delamaire, Transfusion Clinique et Biologique Antigen DensitySection 1BLaboratory HematologyCytometrycoordinatorˈs Report.rhesus IndexBioanalysis	2002	62

Page 1